Clinical Study of Surgically Resected Splenic Tumors.

Accession number;03A0117096
Title;Clinical Study of Surgically Resected Splenic Tumors.
Author; TAMURA AKIRA (Toho Univ., Sch. of Med.) KANEKO HIRONORI (Toho Univ., Sch. of Med.) TAKAGI SUMITO (Toho Univ., Sch. of Med.) KATAGIRI TOSHIO (Toho Univ., Sch. of Med.) MAEDA TETSUYA (Toho Univ., Sch. of Med.) SHIBA TADAAKI (Toho Univ., Sch. of Med.)
Journal Title;Journal of Japan Surgical Association
Journal Code:Z0103A
ISSN:1345-2843
VOL.64;NO.1;PAGE.189-193(2003)
Figure&Table&Reference;FIG.1, TBL.1, REF.18
Pub. Country;Japan
Language;Japanese
Abstract;Surgically resected splenic tumors except malignant lymphomas and splenic cysts in our department were subjected to a study of clinical characteristics. There were two cases of benign tumors (cavernous hemangioma and hamartoma), two cases of primary malignant tumor (angiosarcoma and malignant fibrous histiocytoma) and two cases of metastic tumor (uterus cancer and ovary cancer). Two patients with primary malignant tumor were admitted to the hospital because of abdominal pain, while the other four patients were asymptomatic. No specific findings suggestive of splenic tumors were revealed on abdominal US and CT scan. All six patients were diagnosed by histopathological studies of the resected specimen. Two patients diagnosed as having a primary malignant tumor died within postoperative 6 months, while the remaining patients are still alive. Splenic tumors are extremely rare whether they are benign or malignant. At present, patients with primary malignant tumor of the spleen are promised to have a good prognosis only if the tumor is detected in an early stage while it is silent. And we seldom encounter solitary metastasis so that appropriate postoperative observation can have a great influence on the prognosis. Careful postoperative follow-up and appropriate choice of splenectomy are important. (author abst.)
FULLTEXT